US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

118.78

-0.8100-0.68%

Pre-market: 122.173.39+2.85%08:40 EDT

Volume:9.31M

Turnover:1.11B

Market Cap:7.18B

PE:6.52

High:120.61

Open:119.73

Low:118.28

Close:119.59

52wk High:132.09

52wk Low:66.66

Shares:60.48M

Float Shares:60.48M

Volume Ratio:0.89

T/O Rate:15.39%

Dividend:0.44

Dividend Rate:0.37%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Aura Biosciences Inc (AURA) and Kezar Life Sciences (KZR)

Biotech Alert: Searches spiking for these stocks today

Health Care Roundup: Market Talk

Analysts Offer Insights on Healthcare Companies: Lipocine (LPCN), Viridian Therapeutics (VRDN) and Incyte (INCY)

Press Release: Viva Biotech Announces 2025 Annual Results: AI-Driven Drug Discovery Reinforces Industry Leadership, CDMO Commercial Products Enter Rapid Scale-Up

Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY) and Tenax Therapeutics (TENX)

Viridian: Buy Rating Backed by Differentiated Elegrobart Profile and Growth Potential in a $2B Thyroid Eye Disease Market

Does Doximity’s (DOCS) Scale With Physicians and Cash Flow Redefine Its Healthcare Tech Moat?

Simply Wall St.

Analysts Conflicted on These Healthcare Names: Connect Biopharma Holdings (CNTB), Neumora Therapeutics, Inc. (NMRA) and Merck & Company (MRK)

Analysts Offer Insights on Healthcare Companies: Sight Sciences (SGHT), Atara Biotherapeutics (ATRA) and Rezolute (RZLT)

Modern Healthcare Technology Wins Independent Backing for 2026 Master Lease Deal

Mediwelcome to Acquire Mediai Technology and Raise HK$115 Million via Share Placing

Sector Update: Health Care

MT Newswires Live

Boill Healthcare Outlines Board and Committee Structure

Viva Biotech Profits Rise in 2025 Despite Revenue Decline

Health Care Select Sector SPDR: Pivot points

Novo Nordisk: Solid Wegovy Pill Uptake but Intensifying GLP‑1 Competition Keeps Shares at Hold

Hygeia Healthcare Profit Slumps on Goodwill Hit but Cash Flow and Buybacks Strengthen

Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), AbSci (ABSI) and MaxCyte (MXCT)

Press Release: PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/XBI/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":118.78,"timestamp":1774900800000,"preClose":119.59,"halted":0,"volume":9306190,"hourTrading":{"tag":"盘前","latestPrice":122.17,"preClose":118.78,"latestTime":"08:40 EDT","volume":67543,"amount":8220984.08726,"timestamp":1774960829197,"change":3.39,"changeRate":0.02854,"amplitude":0.021047},"delay":0,"changeRate":-0.0067731415670206725,"floatShares":60475000,"shares":60475000,"eps":18.23,"marketStatus":"Pre-Mkt","change":-0.81,"latestTime":"03-31 08:40:31 EDT","open":119.73,"high":120.61,"low":118.28,"amount":1109526501.0883,"amplitude":0.019483,"askPrice":122.34,"askSize":508,"bidPrice":122.17,"bidSize":200,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774963800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":118.78,"sharesOutstanding":63325000,"nav":119.587592,"aum":6858348395.31,"dividendRate":0.0037,"bidAskSpread":0.000173,"preHourTrading":{"tag":"盘前","latestPrice":122.17,"preClose":118.78,"latestTime":"08:40 EDT","volume":67543,"amount":8220984.08726,"timestamp":1774960829197,"change":3.39,"changeRate":0.02854,"amplitude":0.021047},"postHourTrading":{"tag":"盘后","latestPrice":118.5619,"preClose":118.78,"latestTime":"19:55 EDT","volume":120037,"amount":14281629.3472,"timestamp":1774914947635,"change":-0.2181,"changeRate":-0.001836,"amplitude":0.006776},"volumeRatio":0.8896910242592783,"optionData":{"bulkOrders":[{"symbol":"XBI","call":false,"expireDate":1775793600000,"strike":"110.0","timestamp":1774900789641,"price":0.85,"volume":2293,"amount":194905,"type":"-"},{"symbol":"XBI","call":false,"expireDate":1775793600000,"strike":"117.0","timestamp":1774900789639,"price":2.96,"volume":2293,"amount":678728,"type":"+"}]},"impliedVol":0.4181,"impliedVolPercentile":0.956},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":60475000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8896910242592783,"shares":60475000,"dividePrice":0.4395,"high":120.61,"amplitude":0.019483,"preClose":119.59,"low":118.28,"week52Low":66.66,"pbRate":"--","week52High":132.09,"institutionHeld":0.8511,"latestPrice":118.78,"committee":-0.435028,"eps":18.23,"divideRate":0.0037,"volume":9306190,"delay":0,"ttmEps":18.23,"open":119.73,"prevYearClose":121.93,"prevWeekClose":119.59,"prevMonthClose":127.37,"prevQuarterClose":121.93,"fiveDayClose":121.7,"twentyDayClose":126.55,"sixtyDayClose":121.93},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"},{"date":"2024-12-23","symbol":"XBI","amount":0.002687,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-06-27","value":0.045491,"currency":"USD"},{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2623321125","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Aura Biosciences Inc (AURA) and Kezar Life Sciences (KZR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623321125","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623321125?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:50","pubTimestamp":1774903807,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Aura Biosciences Inc (AURA) and Kezar Life Science...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-aura-biosciences-inc-aura-and-kezar-life-sciences-kzr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-aura-biosciences-inc-aura-and-kezar-life-sciences-kzr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KZR","LU0128526141.USD","XBI","LU0029874061.USD","AURA","BK4137","XLV","BK4585","BK4588","HCSG","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623347698","title":"Biotech Alert: Searches spiking for these stocks today","url":"https://stock-news.laohu8.com/highlight/detail?id=2623347698","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623347698?lang=en_us&edition=fundamental","pubTime":"2026-03-31 00:21","pubTimestamp":1774887662,"startTime":"0","endTime":"0","summary":"These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Alph...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biotech-alert-searches-spiking-for-these-stocks-today-thefly-news-14?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biotech-alert-searches-spiking-for-these-stocks-today-thefly-news-14?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XBI","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623347686","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2623347686","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623347686?lang=en_us&edition=fundamental","pubTime":"2026-03-31 00:20","pubTimestamp":1774887600,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0536 ET - Novartis's first-quarter earnings are set to drop on year, as generic competition and its acquisition of Avidity hit margins, Bank of America analysts say in a research note. Bank of America expects the Swiss pharmaceutical company to report first-quarter core EPS of $2.07, down 10% on year at constant currency and short of consensus estimates of $2.13. The analysts say their forecast for Novartis's quarterly","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSBH","BK4588","BK4521","LU0052756011.USD","LU0976567544.SGD","XLV","LU0496365809.HKD","BK4581","LU2236285917.USD","LU0211326755.USD","BK4585","LABU","LU0310800965.SGD","LU1267930227.SGD","HSBC","LU0128525689.USD","BK4207","LU0211326839.USD","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623445163","title":"Analysts Offer Insights on Healthcare Companies: Lipocine (LPCN), Viridian Therapeutics (VRDN) and Incyte (INCY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623445163","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623445163?lang=en_us&edition=fundamental","pubTime":"2026-03-30 23:20","pubTimestamp":1774884010,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Lipocine (LPCN), Viridian Therapeutics (VRDN) and Incyte (INCY). ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-lipocine-lpcn-viridian-therapeutics-vrdn-and-incyte-incy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-lipocine-lpcn-viridian-therapeutics-vrdn-and-incyte-incy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XBI","LABU","HCSG","INCY","BK4550","BK4137","BK4007","BK4588","XLV","BK4585","LU0128526141.USD","BK4581","VRDN","LU0029874061.USD","BK4532","LPCN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623341287","title":"Press Release: Viva Biotech Announces 2025 Annual Results: AI-Driven Drug Discovery Reinforces Industry Leadership, CDMO Commercial Products Enter Rapid Scale-Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2623341287","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623341287?lang=en_us&edition=fundamental","pubTime":"2026-03-30 23:02","pubTimestamp":1774882920,"startTime":"0","endTime":"0","summary":"Gross profit margin recorded 37.9%, a YOY increase of 3.3 pp. Net profit recorded RMB269.3 million, a YOY increase 21.3%. Adjusted non-IFRS net profit recorded RMB335.3 million, a YOY increase of nearly 6.6%. CRO Business Sustained Recovery in Growth, AI-Enabled Drug Discovery Technology Maintained Industry-Leading Advantages. Throughout 2025, revenue from the Company's CRO business rose from RMB810.9 million in the same period last year to RMB848.6 million, representing a growth of approximately 4.7%. Corresponding adjusted gross profit increased from RMB357.1 million in the same period last year to RMB383.1 million, an increase of approximately 7.3%. The total number of CRO clients of the Company increased to 1,866, including the World's top Ten pharmaceutical companies, revenue from the top ten clients accounted for 25.7% of our total revenue.The Company has continuously strengthened the deployment of new platforms and raised the technical barriers of core platforms, and","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873","BK1576","BK4581","BK1141","BK4585","BK4588","CHAT","XBI","AGIX","CDMO","AIPO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623534924","title":"Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY) and Tenax Therapeutics (TENX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623534924","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623534924?lang=en_us&edition=fundamental","pubTime":"2026-03-30 22:30","pubTimestamp":1774881008,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Butterfly Network (BFLY) and Tenax Therapeutics (TEN...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-butterfly-network-bfly-and-tenax-therapeutics-tenx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-butterfly-network-bfly-and-tenax-therapeutics-tenx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","XBI","LABU","BK4581","BK4137","HCSG","BK4139","XLV","BK4082","BFLY","BK4585","BK4588","LU0128526141.USD","TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623349295","title":"Viridian: Buy Rating Backed by Differentiated Elegrobart Profile and Growth Potential in a $2B Thyroid Eye Disease Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2623349295","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623349295?lang=en_us&edition=fundamental","pubTime":"2026-03-30 22:25","pubTimestamp":1774880721,"startTime":"0","endTime":"0","summary":"Viridian Therapeutics, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Rami Katkhuda from LifeSci Capital main...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/viridian-buy-rating-backed-by-differentiated-elegrobart-profile-and-growth-potential-in-a-2b-thyroid-eye-disease-market-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/viridian-buy-rating-backed-by-differentiated-elegrobart-profile-and-growth-potential-in-a-2b-thyroid-eye-disease-market-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","XLV","BK4588","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623342820","title":"Does Doximity’s (DOCS) Scale With Physicians and Cash Flow Redefine Its Healthcare Tech Moat?","url":"https://stock-news.laohu8.com/highlight/detail?id=2623342820","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623342820?lang=en_us&edition=fundamental","pubTime":"2026-03-30 22:12","pubTimestamp":1774879938,"startTime":"0","endTime":"0","summary":"Doximity recently highlighted that its platform now reaches over 80% of U.S. physicians and has delivered annual revenue growth of about 29.3% over the past five years, while generating strong free cash flow that can be used for investment or capital returns.\nThis combination of broad physician adoption and substantial cash generation underscores Doximity’s position as a core digital tool for clinicians and a financially flexible business within healthcare technology.\nNext, we’ll examine how...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/does-doximitys-docs-scale-with-physicians-and-cash-flow-rede","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/does-doximitys-docs-scale-with-physicians-and-cash-flow-rede","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4581","LU0128526141.USD","BK4551","BK4588","BK4613","BK4539","DOCS","BK4585","AIPO","LABU","HCSG","XLV","BK4167","LU0029874061.USD","XBI","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623456183","title":"Analysts Conflicted on These Healthcare Names: Connect Biopharma Holdings (CNTB), Neumora Therapeutics, Inc. (NMRA) and Merck & Company (MRK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623456183","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623456183?lang=en_us&edition=fundamental","pubTime":"2026-03-30 21:40","pubTimestamp":1774878027,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Connect Biopharma Holdings (CNTB), Neumora Therape...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-connect-biopharma-holdings-cntb-neumora-therapeutics-inc-nmra-and-merck-company-mrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-connect-biopharma-holdings-cntb-neumora-therapeutics-inc-nmra-and-merck-company-mrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0130517989.USD","LU0265550946.USD","LU0432979614.USD","LU1035773651.USD","BK4137","SG9999001440.SGD","LU0058720904.USD","LU2023250504.SGD","LU0238689110.USD","LU1069347547.HKD","IE00BJJMRZ35.SGD","LU0320765489.SGD","BK4533","LU1066051498.USD","LU1093756325.SGD","LU2461242641.AUD","LU0070302665.USD","SG9999001176.USD","BK4550","LU1934455277.USD","BK4581","LU0211331839.USD","IE00BSNM7G36.USD","LU1989771016.USD","LU0265550359.USD","LU1983299246.USD","LU0320765646.SGD","SGXZ57979304.SGD","LU0006306889.USD","BK4516","LU1989772923.USD","LU0648001328.SGD","IE000M9KFDE8.USD","LU0203345920.USD","BK4139","LU2125154935.USD","LU1917777945.USD","LU1037948541.HKD","LABU","MRK","LU1699723380.USD","LU0234572021.USD","SG9999001176.SGD","IE00BFTCPJ56.SGD","IE00BBT3K403.USD","LU0122379950.USD","BK4559","SG9999002232.USD","LU0477156953.USD","LU0106261372.USD","LU2125154778.USD","BK4588","LU0861579265.USD","SG9999014567.USD","LU0029874061.USD","LU1934455194.USD","CNTB","LU2361045086.USD","IE00BJT1NW94.SGD","LU0289739699.SGD","BK4585","SG9999014575.USD","LU1571399168.USD","LU1066051811.HKD","LU2112291526.USD","LU1037948897.HKD","LU1974910355.USD","BK4007","LU0208291251.USD","LU0942090050.USD","LU0203347892.USD","IE00B1BXHZ80.USD","LU1061106388.HKD","IE00B4R5TH58.HKD","LU0965509101.SGD","LU1066051225.USD","LU0965509010.AUD","LU1291159041.SGD","SG9999014559.SGD","SG9999015358.SGD","SG9999002224.SGD","LU1162221912.USD","LU2360032135.SGD","LU0130102774.USD","LU0266013472.USD","IE0002141913.USD","LU1201861249.SGD","IE00B2B36J28.USD","NMRA","IE00BLSP4452.SGD","LU2023250843.SGD","BK4534","IE00BLSP4239.USD","LU1023059063.AUD","LU2324357040.USD","LU0985320562.USD","LU0980610538.SGD","LU1057294990.SGD","SG9999014542.SGD","LU2361044865.SGD","XBI","IE0009355771.USD","LU2106854487.HKD","LU1066053197.SGD","LU1941712264.USD","LU2361044949.HKD","LU0965508806.USD","LU0965509283.SGD","LU0868494708.USD","LU1116320737.USD","LU1934455863.HKD","LU0868494617.USD","LU1929549753.HKD","SG9999015341.SGD","LU1989772840.SGD","LU1941712348.USD","LU1116320901.HKD","IE00BN8TJ469.HKD","SG9999013999.USD","LU1585245621.USD","LU1430594728.SGD","LU1093756168.USD","LU2089984988.USD","LU0128526141.USD","LU2468319806.SGD","LU0098860793.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623734398","title":"Analysts Offer Insights on Healthcare Companies: Sight Sciences (SGHT), Atara Biotherapeutics (ATRA) and Rezolute (RZLT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623734398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623734398?lang=en_us&edition=fundamental","pubTime":"2026-03-30 21:10","pubTimestamp":1774876258,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sight Sciences (SGHT), Atara Biotherapeutics (ATRA) ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sight-sciences-sght-atara-biotherapeutics-atra-and-rezolute-rzlt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sight-sciences-sght-atara-biotherapeutics-atra-and-rezolute-rzlt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0128526141.USD","BK4539","ATRA","SGHT","XBI","LU0029874061.USD","RZLT","BK4137","BK4082","BK4585","BK4588","HCSG","XLV","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623134845","title":"Modern Healthcare Technology Wins Independent Backing for 2026 Master Lease Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2623134845","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623134845?lang=en_us&edition=fundamental","pubTime":"2026-03-30 21:00","pubTimestamp":1774875616,"startTime":"0","endTime":"0","summary":"An update from Modern Healthcare Technology Holdings Limited ( ($HK:0919) ) is now available. Independent shareholders of Modern Healthcare Technol...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/modern-healthcare-technology-wins-independent-backing-for-2026-master-lease-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/modern-healthcare-technology-wins-independent-backing-for-2026-master-lease-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","XBI","LU0029874061.USD","BK4137","XLV","BK4588","BK4585","HCSG","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623481703","title":"Mediwelcome to Acquire Mediai Technology and Raise HK$115 Million via Share Placing","url":"https://stock-news.laohu8.com/highlight/detail?id=2623481703","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623481703?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:57","pubTimestamp":1774875463,"startTime":"0","endTime":"0","summary":"Mediwelcome Healthcare Management & Technology Inc. ( ($HK:2159) ) has shared an update. Mediwelcome Healthcare Management & Technology Inc. has ag...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mediwelcome-to-acquire-mediai-technology-and-raise-hk115-million-via-share-placing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mediwelcome-to-acquire-mediai-technology-and-raise-hk115-million-via-share-placing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4585","LABU","XBI","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623485583","title":"Sector Update: Health Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2623485583","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623485583?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:57","pubTimestamp":1774875423,"startTime":"0","endTime":"0","summary":"Health care stocks were flat to higher pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF  inactive and the iShares Biotechnology ETF  up 0.9%.United Therapeutics  shares were up more than 16% after the company said a pivotal study of nebulized Tyvaso in idiopathic pulmonary fibrosis met the primary efficacy endpoint, increasing forced vital capacity by 130.1 mL at 52 weeks and reducing the risk of clinical worsening compared with placebo.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","IBB","BK4139","BK4585","LABU","UTHR","XLV","LU1571399168.USD","XBI","LU1699723380.USD","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623348437","title":"Boill Healthcare Outlines Board and Committee Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2623348437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623348437?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:55","pubTimestamp":1774875329,"startTime":"0","endTime":"0","summary":"An update from Boill Healthcare Holdings Limited ( ($HK:1246) ) is now available. Boill Healthcare Holdings Limited has announced the current compo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/boill-healthcare-outlines-board-and-committee-structure-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/boill-healthcare-outlines-board-and-committee-structure-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4581","HCSG","XBI","XLV","BK4137","BK4588","LABU","LU0128526141.USD","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623348162","title":"Viva Biotech Profits Rise in 2025 Despite Revenue Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2623348162","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623348162?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:55","pubTimestamp":1774875316,"startTime":"0","endTime":"0","summary":"Viva Biotech Holdings ( ($HK:1873) ) has issued an update. Viva Biotech Holdings reported 2025 revenue of RMB 1.73 billion, down 12.9% from a year ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/viva-biotech-profits-rise-in-2025-despite-revenue-decline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/viva-biotech-profits-rise-in-2025-despite-revenue-decline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623731025","title":"Health Care Select Sector SPDR: Pivot points","url":"https://stock-news.laohu8.com/highlight/detail?id=2623731025","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623731025?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:38","pubTimestamp":1774874290,"startTime":"0","endTime":"0","summary":"The following are the pivot points for the Health Care Select Sector SPDR (XLV). Pivot High: $144.53, Pivot Low: $141.80. These were calculated usi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-31?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-31?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LABU","BK4588","XLV","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623794312","title":"Novo Nordisk: Solid Wegovy Pill Uptake but Intensifying GLP‑1 Competition Keeps Shares at Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2623794312","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623794312?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:55","pubTimestamp":1774871736,"startTime":"0","endTime":"0","summary":"Novo Nordisk, the Healthcare sector company, was revisited by a Wall Street analyst on March 27. Analyst Evan Seigerman from BMO Capital maintained...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/novo-nordisk-solid-wegovy-pill-uptake-but-intensifying-glp‑1-competition-keeps-shares-at-hold-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/novo-nordisk-solid-wegovy-pill-uptake-but-intensifying-glp‑1-competition-keeps-shares-at-hold-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0154236417.USD","BK4581","LU1093756325.SGD","BK4585","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","NVO","BK4588","BK4590","BK4599","BK4007","BK4532","LABU","NVOH","LU1093756168.USD","BK4144","NVOX","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623312014","title":"Hygeia Healthcare Profit Slumps on Goodwill Hit but Cash Flow and Buybacks Strengthen","url":"https://stock-news.laohu8.com/highlight/detail?id=2623312014","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623312014?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:55","pubTimestamp":1774871704,"startTime":"0","endTime":"0","summary":"Hygeia Healthcare Holdings Co., Ltd. ( ($HK:6078) ) has issued an announcement. Hygeia Healthcare reported 2025 revenue of RMB4,008.8 million, down...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hygeia-healthcare-profit-slumps-on-goodwill-hit-but-cash-flow-and-buybacks-strengthen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hygeia-healthcare-profit-slumps-on-goodwill-hit-but-cash-flow-and-buybacks-strengthen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0128526141.USD","XBI","BK4585","LU0029874061.USD","HCSG","XLV","BK4581","BK4137","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623311622","title":"Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), AbSci (ABSI) and MaxCyte (MXCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623311622","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623311622?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:02","pubTimestamp":1774868523,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on MoonLake Immunotherapeutics (MLTX), AbSci (ABSI) and...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-moonlake-immunotherapeutics-mltx-absci-absi-and-maxcyte-mxct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-moonlake-immunotherapeutics-mltx-absci-absi-and-maxcyte-mxct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LABU","MXCT","XBI","HCSG","MLTX","XLV","BK4539","BK4585","BK4121","BK4137","BK4581","LU0029874061.USD","LU0128526141.USD","BK4588","ABSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623931165","title":"Press Release: PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement","url":"https://stock-news.laohu8.com/highlight/detail?id=2623931165","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623931165?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:01","pubTimestamp":1774868460,"startTime":"0","endTime":"0","summary":"Filed Phase 3 Amendment Incorporates PFS as Interim Primary Endpoint Expected to Shorten Trial Duration and Reduce Costs. Conference Call and Webcast Today at 8:00 am Eastern Time. PRINCETON, N.J., March 30, 2026  -- PDS Biotechnology Corporation  , a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today provided a business and clinical programs update and reported financial results for the quarter and year ended December 31, 2025.Dr. Bedu-Addo added: \"Combined with early data from one of our PDS01ADC Phase 2 programs and expanded patent protections for the Versamune platform extending into the 2040s, we believe we have meaningful opportunities ahead as we continue to execute against our priorities in 2026.\". median PFS of 9.6 months and a median PSA decline of 40%, with 6 of 16","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4092","BK4231","BK4080","ADC","BK4022","PDS","R","XBI","BK4139","BK4232","BK4588","BK4585","PDSB","PFS","BK4195","BK4581","BK4211"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":2,"totalSize":394,"code":"91000000","status":"200"}]}}